Rhabdomyolysis by Levetiracetam?

被引：0
|
作者：
Rating, D.
机构：
来源：
ZEITSCHRIFT FUR EPILEPTOLOGIE | 2015年 / 28卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：165 / 165
页数：1
相关论文
共 50 条
  • [21] Shaking Up a Storm: Levetiracetam Induced Rhabdomyolysis - An Exceedingly Rare Complication
    Patel, M. P.
    Zuniega, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [22] Levetiracetam-Induced Rhabdomyolysis Following Medication Re-Initiation
    Boucher, Klayme-Shane
    Dedhia, Neilay
    Bommisetty, Deepak
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (10)
  • [23] Suspected Levetiracetam-Induced Rhabdomyolysis: A Case Report and Literature Review
    Moinuddin, Imran A.
    AMERICAN JOURNAL OF CASE REPORTS, 2020, 21 : 1 - 4
  • [24] Antineoplastics/levetiracetam/pregabalinImmune-related hypothyroidism, rhabdomyolysis and creatine phosphokinase elevation: case report
    Reactions Weekly, 2022, 1894 (1) : 47 - 47
  • [25] Suspected Levetiracetam-Induced Acute Rhabdomyolysis in a Patient With Retinoblastoma: A Case Report and Literature Review
    Alshehabi, Khadija M.
    Askandarani, Sumayah
    Alkhalifah, Zainab A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (05)
  • [26] Real-world analysis of levetiracetam-associated rhabdomyolysis: insights from the FDA adverse event reporting system
    Guo, Yinan
    Gong, Guangming
    Guo, Guangyu
    Cheng, Xianghai
    Yin, Jingwen
    Qin, Jie
    EXPERT OPINION ON DRUG SAFETY, 2025, 24 (03) : 377 - 388
  • [27] Levetiracetam-induced rhabdomyolysis: Analysis of reports from the Food and Drug Administration's Adverse Event Reporting System database
    Carnovale, Carla
    Gentili, Marta
    Antoniazzi, Stefania
    Clementi, Emilio
    Radice, Sonia
    MUSCLE & NERVE, 2017, 56 (06) : E176 - E178
  • [28] Levetiracetam
    不详
    DRUGS OF THE FUTURE, 2002, 27 (04) : 419 - 420
  • [29] Levetiracetam
    Haria, M
    Balfour, JA
    CNS DRUGS, 1997, 7 (02) : 159 - 164
  • [30] Levetiracetam
    Nash, EM
    Sangha, KS
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (13) : 1195 - 1199
12345